Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription

被引:141
作者
Christensen, J
Cloos, P
Toftegaard, U
Klinkenberg, D
Bracken, AP
Trinh, E
Heeran, M
Di Stefano, L
Helin, K
机构
[1] BRIC, DK-2100 Copenhagen, Denmark
[2] European Inst Oncol, I-20141 Milan, Italy
[3] Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark
关键词
D O I
10.1093/nar/gki855
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E2F family of transcription factors are downstream effectors of the retinoblastoma protein, pRB, pathway and are essential for the timely regulation of genes necessary for cell-cycle progression. Here we describe the characterization of human and murine E2F8, a new member of the E2F family. Sequence analysis of E2F8 predicts the presence of two distinct E2F-related DNA binding domains suggesting that E2F8 and, the recently, identified E2F7 form a subgroup within the E2F family. We show that E2F transcription factors bind the E2F8 promoter in vivo and that expression of E2F8 is being induced at the G1/S transition. Purified recombinant E2F8 binds specifically to a consensus E2F-DNA-binding site indicating that E2F8, like E2F7, binds DNA without the requirement of co-factors such as DP1. E2F8 inhibits E2F-driven promoters suggesting that E2F8 is transcriptional repressor like E2F7. Ectopic expression of E2F8 in diploid human fibroblasts reduces expression of E2F-target genes and inhibits cell growth consistent with a role for repressing E2F transcriptional activity. Taken together, these data suggest that E2F8 has an important role in turning of the expression of E2F-target genes in the S-phase of the cell cycle.
引用
收藏
页码:5458 / 5470
页数:13
相关论文
共 24 条
[1]  
ANG XL, 2004, SCI STKE, pPE31
[2]   The E2F family: specific functions and overlapping interests [J].
Attwooll, C ;
Denchi, EL ;
Helin, K .
EMBO JOURNAL, 2004, 23 (24) :4709-4716
[3]   Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis [J].
Andrea Ballabeni ;
Marina Melixetian ;
Raffaella Zamponi ;
Laura Masiero ;
Federica Marinoni ;
Kristian Helin .
The EMBO Journal, 2004, 23 (15) :3122-3132
[4]   Discovery of new potentially defective alleles of human CYP2C9 [J].
Blaisdell, J ;
Jorge-Nebert, LF ;
Coulter, S ;
Ferguson, SS ;
Lee, SJ ;
Chanas, B ;
Xi, T ;
Mohrenweiser, H ;
Ghanayem, B ;
Goldstein, JA .
PHARMACOGENETICS, 2004, 14 (08) :527-537
[5]   E2F target genes: unraveling the biology [J].
Bracken, AP ;
Ciro, M ;
Cocito, A ;
Helin, K .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (08) :409-417
[6]   The retinoblastoma tumour suppressor in development and cancer [J].
Classon, M ;
Harlow, E .
NATURE REVIEWS CANCER, 2002, 2 (12) :910-917
[7]   Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation [J].
de Bruin, A ;
Maiti, B ;
Jakoi, L ;
Timmers, C ;
Buerki, R ;
Leone, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :42041-42049
[8]   E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes [J].
Di Stefano, L ;
Jensen, MR ;
Helin, K .
EMBO JOURNAL, 2003, 22 (23) :6289-6298
[9]   The E2F transcriptional network: old acquaintances with new faces [J].
Dimova, DK ;
Dyson, NJ .
ONCOGENE, 2005, 24 (17) :2810-2826
[10]   A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription [J].
Giangrande, PH ;
Zhu, WC ;
Schlisio, S ;
Sun, X ;
Mori, S ;
Gaubatz, S ;
Nevins, JR .
GENES & DEVELOPMENT, 2004, 18 (23) :2941-2951